Redsense Medical AB (REDS) — Cash Flow Reinvestment Rate

Latest as of March 2025: 0.14x

Redsense Medical AB (REDS) has a Cash Flow Reinvestment Rate of 0.14x as of March 2025, reinvesting Skr105.00K (capex Skr105.00K ) from operating cash flow of Skr761.00K. Check cash flow quality index of Redsense Medical AB to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.14x
(Capex + Investments) / Operating CF

Total Reinvested

Skr105.00K
Capex + Investments

Operating Cash Flow

Skr761.00K
SEK

Capital Expenditures

Skr105.00K
SEK

Redsense Medical AB Cash Flow Reinvestment Rate (2020–2020)

Historical reinvestment intensity for Redsense Medical AB across 1 annual periods. Explore Redsense Medical AB (REDS) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Redsense Medical AB (2020–2020)

Year-by-year capital reinvestment analysis for Redsense Medical AB. For live market cap and broader valuation context, see market value of Redsense Medical AB.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2020 5.90x Skr101.62 Million Skr17.23 Million Skr37.08 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow